Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
We have previously reported that loss of p53 tumor suppressor protein results in centrosome hyperamplification, which leads to aberrant mitosis and chromosome instability. Since p53 is either deleted or mutated in human cancers at a high frequency, we investigated whether human cancers showed centrosome hyperamplification. Screening of advanced stage breast ductal carcinomas and squamous cell carcinomas of the head and neck (SCCHN) revealed that centrosome hyperamplification is frequent in both tumor types. Moreover, through the analyses of p53 in SCCHN samples by direct sequencing and by loss-of-heterozygosity test, we found that p53 mutations correlated with occurrence of centrosome hyperamplification. However, in some cases, we observed centrosome hyperamplification in tumors that retained wild-type p53. These tumors contained high levels of Mdm2. Since Mdm2 can inactivate p53 through physical association, we investigated whether Mdm2 overexpression induced centrosome hyperamplification. We found that Mdm2 overexpression, like loss of p53, induced centrosome hyperamplification and chromosome instability in cultured cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies have shown that Mdm2 overexpression can promote certain forms of genome instability, such as aneuploidy and centrosome duplication (9, 50).”
From Mdm2 Promotes Genetic Instability and Transformation Independent of p53 (2008) · cites this paper as [9]
In the citing paper
“higher levels are incompatible with life in vivo and in vitro, except in some cases when p53 is also inactivated”
From The Mdm network and its regulation of p53 activities: a rheostat of cancer risk (2014) · cites this paper as Carroll, et al., 1999
In the citing paper
“Small increases in Mdm2 levels in normal cells are tolerated”
From The Mdm network and its regulation of p53 activities: a rheostat of cancer risk (2014) · cites this paper as Carroll, et al., 1999
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018 · cited 2×
“The p53 tumor suppressor gene is the most frequently mutated gene in human cancer (Hollstein et al., 1991; Levine et al., 1991).”
BackgroundMdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 2×
“…proteosome pathway *Correspondence: K Fukasawa Received 20 July 1998; revised 1 October 1998; accepted 23 October 1998 Oncogene (1999) 18, 1935 ± 1944 ã 1999 Stockton Press All rights reserved 0950 ± 9232/99 $12.00 http://www.stockton-press.co.uk/onc (Haupt et al., 1997; Kubbutat et al., 1997).”
BackgroundInfluentialThe p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788 · cited 2×
“The p53 tumor suppressor gene is the most frequently mutated gene in human cancer (Hollstein et al., 1991; Levine et al., 1991).”
BackgroundRegulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 4×
“…proteosome pathway *Correspondence: K Fukasawa Received 20 July 1998; revised 1 October 1998; accepted 23 October 1998 Oncogene (1999) 18, 1935 ± 1944 ã 1999 Stockton Press All rights reserved 0950 ± 9232/99 $12.00 http://www.stockton-press.co.uk/onc (Haupt et al., 1997; Kubbutat et al., 1997).”
BackgroundInfluentialMomand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · cited 1×
“Mdm2 binds to p53 at the Nterminal transactivating domain, and inhibits the transactivation function of p53 (Momand et al., 1992; Oliner et al., 1993; Chen et al., 1993; Picksley et al., 1994).”
BackgroundBloom, H. J. G., & Richardson, W. W. (1957) · British Journal of Cancer · doi:10.1038/bjc.1957.43 · Cited by 2,925 · cited 1×
“A total of eight breast ductal carcinomas [grade III (Bloom-Richardson grade, Bloom and Richardson, 1957), poorly di erentiated, lymph node positive], and 12 SCCHN [stage 3 and 4 (UICC), poorly to moderately di erentiated, lymph node positive] were examined.”
BackgroundGenetic instability in colorectal cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386623a0 · Cited by 1,986 · cited 1×
“Some previous studies have failed to detect a clear correlation between the p53 mutation and chromosome instability (Lengauer et al., 1997).”
BackgroundAmplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949 · cited 3×
“Importantly, the ampli®cation of Mdm2 occurs preferentially in tumors that do not have p53 mutations (Oliner et al., 1992).”
BackgroundMethodInfluentialVariable Number of Tandem Repeat (VNTR) Markers for Human Gene Mapping
Nakamura, Y., Leppert, M., O'Connell, P., Wolff, R., Holm, T., Culver, M., Martin, C., Fujimoto, E., Hoff, M., Kumlin, E., et al. (1987) · Science · doi:10.1126/science.3029872 · Cited by 1,654 · cited 1×
“…(LOH) test and sequence analysis of p53 In order to detect LOH of p53 on chromosome 17, the probes p144-D6 and pYNZ22 were used to detect variable number of tandem repeat markers as described previously (Kondoleon et al., 1987; Vissing et al., 1987; Nakamura et al., 1987; Gleich et al., 1996).”
MethodOncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,451 · cited 1×
“Mdm2 binds to p53 at the Nterminal transactivating domain, and inhibits the transactivation function of p53 (Momand et al., 1992; Oliner et al., 1993; Chen et al., 1993; Picksley et al., 1994).”
BackgroundAltered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., & Tlsty, T. D. (1992) · Cell · doi:10.1016/0092-8674(92)90243-6 · Cited by 1,332 · cited 2×
“For mitotic cells, 4200 cells were examined mutated (Yin et al., 1992; Livingstone et al., 1992).”
BackgroundYin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., & Wahl, G. M. (1992) · Cell · doi:10.1016/0092-8674(92)90244-7 · Cited by 1,089 · cited 2×
“For mitotic cells, 4200 cells were examined mutated (Yin et al., 1992; Livingstone et al., 1992).”
BackgroundIncreased expression of mutant forms of p53 oncogene in primary lung cancer
Iggo, R., Bartek, J., Lane, D., Gatter, K., Harris, A. L., & Bartek, J. (1990) · The Lancet · doi:10.1016/0140-6736(90)90801-b · Cited by 1,031 · cited 1×
“…of p53, Pab246 that reacts only with the wild-type conformation, and Pab240 that reacts only with the mutant conformation (Yewdell et al., 1986; Gannon et al., 1990; Iggo et al., 1990). p53 proteins in both Mdm2-pool 1 and pool 2 were detected by Pab421 and Pab246, but not by Pab240 (Figure 4).”
BackgroundAbnormal Centrosome Amplification in the Absence of p53
Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S., & Woude, G. F. V. (1996) · Science · doi:10.1126/science.271.5256.1744 · Cited by 797 · cited 2×
“Examination of p537/7 mouse embro- nic ®broblasts as well as p537/7 mice revealed that loss of p53 leads to centrosome hyperampli®cation, which in turn increases the incidence of aberrant mitosis and chromosome instability (Fukasawa et al., 1996, 1997).”
BackgroundSelf-citationPresence of a Potent Transcription Activating Sequence in the p53 Protein
Fields, S., & Jang, S. K. (1990) · Science · doi:10.1126/science.2144363 · Cited by 790
Fakharzadeh, S. S., Trusko, S. P., & George, D. L. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07676.x · Cited by 704 · cited 1×
“It was subsequently established as an oncogene, since overexpression of Mdm2 in cultured cells increased the tumorigenic potential of these cells (Fakharzadeh et al., 1991; Finlay, 1993).”
BackgroundMapping of the p53 and mdm-2 interaction domains.
Chen, J., Marechal, V, & Levine, A. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4107 · Cited by 689 · cited 1×
“Mdm2 binds to p53 at the Nterminal transactivating domain, and inhibits the transactivation function of p53 (Momand et al., 1992; Oliner et al., 1993; Chen et al., 1993; Picksley et al., 1994).”
BackgroundGannon, J. V., Greaves, R., Iggo, R., & Lane, D. P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08279.x · Cited by 688 · cited 1×
“…of p53, Pab246 that reacts only with the wild-type conformation, and Pab240 that reacts only with the mutant conformation (Yewdell et al., 1986; Gannon et al., 1990; Iggo et al., 1990). p53 proteins in both Mdm2-pool 1 and pool 2 were detected by Pab421 and Pab246, but not by Pab240 (Figure 4).”
Backgroundγ-Tubulin is a highly conserved component of the centrosome
Stearns, T., Evans, L., & Kirschner, M. (1991) · Cell · doi:10.1016/0092-8674(91)90390-k · Cited by 564 · cited 1×
“The g-tubulin is a major component of centrosomes, and immunostaining for g-tubulin detects centrosomes throughout the cell cycle (Zheng et al., 1991; Stearns et al., 1991; Joshi et al., 1992).”
BackgroundSpontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.
Harvey, M., McArthur, M. J., Montgomery, C. A., Butel, J. S., Bradley, A., & Donehower, L. A. (1993) · Nature Genetics · doi:10.1038/ng1193-225 · Cited by 542 · cited 3×
“Moreover, cytogenetic analysis of cultured ®broblasts, as well as tissues derived from p537/7 mice have revealed a high degree of aneuploidy (Harvey et al., 1993b; Purdie et al., 1994; Donehower et al., 1995; Bou er et al., 1995; Fukasawa et al., 1997) and spontaneous gene ampli®cation of certain…”
BackgroundResultReid, B., Blount, P., Rubin, C., Levine, D., Haggitt, R., & Rabinovitch, P. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)70015-4 · Cited by 468 · cited 1×
“In an experimental system, emergence of aneuploidy has been shown to be strongly correlated with the acquisition of invasive and metastatic phenotypes (Reid et al., 1992).”
Backgroundγ-Tubulin is a centrosomal protein required for cell cycle-dependent microtubule nucleation
Joshi, H. C., Palacios, M. J., McNamara, L., & Cleveland, D. W. (1992) · Nature · doi:10.1038/356080a0 · Cited by 445 · cited 1×
“The g-tubulin is a major component of centrosomes, and immunostaining for g-tubulin detects centrosomes throughout the cell cycle (Zheng et al., 1991; Stearns et al., 1991; Joshi et al., 1992).”
BackgroundMicrotubule Organizing Centers
Brinkley, B. R. (1985) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.01.110185.001045 · Cited by 414
Zheng, Y., Jung, M. K., & Oakley, B. R. (1991) · Cell · doi:10.1016/0092-8674(91)90389-g · Cited by 398
Cahilly-Snyder, L., Yang-Feng, T., Francke, U., & George, D. L. (1987) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01535205 · Cited by 355 · cited 1×
“The mdm2 was initially identi®ed as an ampli®ed gene on a murine doubleminute chromosome in the spontaneously transformed BALB/c 3T3 cells (Cahilly-Snyder et al., 1987).”
BackgroundMDM2 gene amplification in metastatic osteosarcoma.
Ladanyi, M., Cha, C. H., Lewis, R., Jhanwar, S. C., Huvos, A. G., & Healey, J. H. (1993) · PubMed · Cited by 340
The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.
Finlay, C. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.301 · Cited by 311 · cited 1×
“It was subsequently established as an oncogene, since overexpression of Mdm2 in cultured cells increased the tumorigenic potential of these cells (Fakharzadeh et al., 1991; Finlay, 1993).”
BackgroundDonehower, L. A., Godley, L. A., Aldaz, C. M., Pyle, R., Shi, Y. P., Pinkel, D., Gray, J., Bradley, A., Medina, D., & Varmus, H. E. (1995) · Genes & Development · doi:10.1101/gad.9.7.882 · Cited by 276 · cited 3×
“…®broblasts, as well as tissues derived from p537/7 mice have revealed a high degree of aneuploidy (Harvey et al., 1993b; Purdie et al., 1994; Donehower et al., 1995; Bou er et al., 1995; Fukasawa et al., 1997) and spontaneous gene ampli®cation of certain genes, including c-myc and DHFR…”
BackgroundResultMdm2: keeping p53 under control
Piette, J., Neel, H., & Maréchal, V. (1997) · Oncogene · doi:10.1038/sj.onc.1201432 · Cited by 266 · cited 1×
“It has been proposed that Mdm2 binding prevents the interaction between essential transcription factors and p53 (reviewed in Momand and Zambetti, 1997; Piette et al., 1997).”
BackgroundMonoclonal antibody analysis of p53 expression in normal and transformed cells
Yewdell, J. W., Gannon, J. V., & Lane, D. P. (1986) · Journal of Virology · doi:10.1128/jvi.59.2.444-452.1986 · Cited by 264 · cited 1×
“…and mutant conformations of p53, Pab246 that reacts only with the wild-type conformation, and Pab240 that reacts only with the mutant conformation (Yewdell et al., 1986; Gannon et al., 1990; Iggo et al., 1990). p53 proteins in both Mdm2-pool 1 and pool 2 were detected by Pab421 and Pab246, but…”
BackgroundChemically induced aneuploidy in mammalian cells: Mechanisms and biological significance in cancer
Oshimura, M., & Barrett, J. C. (1986) · Environmental Mutagenesis · doi:10.1002/em.2860080112 · Cited by 254 · cited 1×
“Moreover, the ploidy changes become more apparent at later stages of tumor progression (Oshimura and Barrett, 1986; Holliday, 1989).”
Backgroundp53 Protein Exhibits 3′-to-5′ Exonuclease Activity
Mummenbrauer, T., Janus, F., Müller, B., Wiesmüller, L., Deppert, W., & Grosse, F. (1996) · Cell · doi:10.1016/s0092-8674(00)81309-4 · Cited by 249
Genomic instability and apoptosis are frequent in p53 deficient young mice
Fukasawa, K., Wiener, F., Woude, G. F. V., & Mai, S. (1997) · Oncogene · doi:10.1038/sj.onc.1201482 · Cited by 195 · cited 7×
“This results in increased error of chromosome transmission to the daughter cells (Fukasawa et al., 1996, 1997).”
BackgroundMethodResultInfluentialSelf-citationGenomic Instability and Tumor Progression: Mechanistic Considerations
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60824-6 · Cited by 174
The p53 tumor suppressor gene in breast cancer
Elledge, R. M., & Allred, D. C. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666204 · Cited by 171
Momand, J., & Zambetti, G. P. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19970301)64:3<343::aid-jcb1>3.0.co;2-v · Cited by 168 · cited 2×
“It has been proposed that Mdm2 binding prevents the interaction between essential transcription factors and p53 (reviewed in Momand and Zambetti, 1997; Piette et al., 1997).”
Backgroundp53 overexpression in head and neck squamous cell carcinoma: Review of the literature
Raybaud-Diogène, H., Têtu, B., Morency, R., Fortin, A., & Monteil, R. A. (1996) · European Journal of Cancer Part B Oral Oncology · doi:10.1016/0964-1955(95)00095-x · Cited by 138 · cited 2×
“We particularly examined breast ductal carcinomas and squamous cell carcinomas of head and neck (SCCHN), both of which have been shown to harbor p53 mutations at high frequencies (Elledge and Allred, 1994; Ozbun and Butel, 1995; Eyfjord et al., 1995; Raybaud-Diogene et al., 1996).”
BackgroundSpontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice.
Bouffler, S. D., Kemp, C. J., Balmain, A., & Cox, R. (1995) · PubMed · Cited by 121
Genomic instability and the role of p53 mutations in cancer cells
Smith, M. L., & Fornace, A. J. (1995) · Current Opinion in Oncology · doi:10.1097/00001622-199501000-00011 · Cited by 119 · cited 1×
“Numerous studies of various human tumors have also shown a strong correlation between mutated or deleted p53 and emergence of aneuploidy (Carder et al., 1993; Blount et al., 1994; also reviewed in Smith and Fornace, 1995).”
BackgroundChromosome error propagation and cancer
Holliday, R. (1989) · Trends in Genetics · doi:10.1016/0168-9525(89)90020-6 · Cited by 108 · cited 1×
“Moreover, the ploidy changes become more apparent at later stages of tumor progression (Oshimura and Barrett, 1986; Holliday, 1989).”
Backgroundp53 abnormalities and genomic instability in primary human breast carcinomas.
Eyfjörd, J. E., Thorlacius, S., Steinarsdóttir, M., Valgardsdottir, R., Ogmundsdottir, H. M., & Anamthawat‐Jónsson, K. (1995) · PubMed · Cited by 105
Tumor Suppressor p53 Mutations and Breast Cancer: A Critical Analysis
Ozbun, M. A., & Butel, J. S. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60252-3 · Cited by 103 · cited 2×
“We particularly examined breast ductal carcinomas and squamous cell carcinomas of head and neck (SCCHN), both of which have been shown to harbor p53 mutations at high frequencies (Elledge and Allred, 1994; Ozbun and Butel, 1995; Eyfjord et al., 1995; Raybaud-Diogene et al., 1996).”
BackgroundGenomic instability and the role of p53 mutations in cancer cells
Smith, M. L., & Fornace, A. J. (1995) · Current Opinion in Oncology · doi:10.1097/00001622-199507010-00011 · Cited by 93
Kondoleon, S. K., Vissing, H., Luo, X. Y., Magenis, R. E., Kellogg, J. A., & Litt, M. J. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.24.10605 · Cited by 56 · cited 1×
“…(LOH) test and sequence analysis of p53 In order to detect LOH of p53 on chromosome 17, the probes p144-D6 and pYNZ22 were used to detect variable number of tandem repeat markers as described previously (Kondoleon et al., 1987; Vissing et al., 1987; Nakamura et al., 1987; Gleich et al., 1996).”
MethodStructure and Functions of Isolated Centrosomes
Bornens, M. (1992) · Elsevier eBooks · doi:10.1016/b978-0-12-394770-3.50006-1 · Cited by 41 · cited 1×
“In somatic cells, centrosome duplication begins near the G1/S boundary of the cell cycle as replication of the centriole, the core component of the centrosome in mammalian cells, commences, and is completed in G2-phase (reviewed in Brinkley, 1985; Vandre and Borisy, 1989; Bornens, 1992).”
BackgroundGleich, L. L., Li, Y., Biddinger, P. W., Gartside, P. S., Stambrook, P. J., Pavelić, Z. P., & Gluckman, J. L. (1996) · The Laryngoscope · doi:10.1097/00005537-199611000-00013 · Cited by 40 · cited 3×
“…(LOH) test and sequence analysis of p53 In order to detect LOH of p53 on chromosome 17, the probes p144-D6 and pYNZ22 were used to detect variable number of tandem repeat markers as described previously (Kondoleon et al., 1987; Vissing et al., 1987; Nakamura et al., 1987; Gleich et al., 1996).”
BackgroundMethodSelf-citationProgress towards construction of a total restriction fragment map of a human chromosome
Vissing, H., Grosveld, F. G., Solomon, E., Moore, G., Lench, N., Shennen, N., & Williamson, R. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.4.1363 · Cited by 28 · cited 1×
“…(LOH) test and sequence analysis of p53 In order to detect LOH of p53 on chromosome 17, the probes p144-D6 and pYNZ22 were used to detect variable number of tandem repeat markers as described previously (Kondoleon et al., 1987; Vissing et al., 1987; Nakamura et al., 1987; Gleich et al., 1996).”
MethodExcess Wild-Type p53 Blocks Initiation and Maintenance of Simian Virus 40 Transformation
Fukasawa, K., Sakoulas, G., Pollack, R., & Chen, S. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.7.3472 · Cited by 27
Self-citationEvidence that immunological variants of p53 represent alternative protein conformation
Gamble, J. A., & Milner, J. (1988) · Virology · doi:10.1016/0042-6822(88)90486-2 · Cited by 26 · cited 3×
“The lysates containing 200 mg of total proteins were immunoprecipitated with the following anti-p53 monoclonal antibodies: Pab421 (Oncogene Science), Pab246 and Pab240 (Santa Cruz).”
BackgroundInfluentialOverexpression of p53 protein is common in premalignant head and neck lesions.
Zp, P., Yq, L., Stambrook, P. J., McDonald, J. S., Munck‐Wikland, E., Pavelić, K., Dacic, S., Danilović, Z., Pavelic, L., & Mugge, R. E. (1994) · PubMed · Cited by 24
Self-citationExcess Wild-Type p53 Blocks Initiation and Maintenance of Simian Virus 40 Transformation
Fukasawa, K., Sakoulas, G., Pollack, R., & Chen, S. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.7.3472-3483.1991 · Cited by 7 · cited 1×
“Swiss 3T3 cells have been shown to retain wild-type p53 (Fukasawa et al., 1991).”
BackgroundSelf-citation
Research works printed but not linked: 3
- Chen J, Marechal V and Levine A. . 1993 Mol. Cell. Biol. 13: 4107–4114. · DOI · Paper page
- Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC and Rabinovtich PS. . 1992 Gastroenterology 102: 1212–1219. · doi:10.1016/0016-5085(92)90758-q · Paper page
- Vandre DD and Borisy GG. . (1989) The centrosome cycle in animal cells. In Mitosis: Molecules and Mechanisms. Hyams JS and Brinkley BR (eds). Academic Press: San Diego pp.39–75.
Cited by
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1902 · Cited by 2,185
Centrosome aberrations: cause or consequence of cancer progression?
Nigg, E. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc924 · Cited by 732
Nucleophosmin/B23 Is a Target of CDK2/Cyclin E in Centrosome Duplication
Okuda, M., Horn, H. F., Tarapore, P., Tokuyama, Y., Smulian, A. G., Chan, P.-K., Knudsen, E. S., Hofmann, I. A., Snyder, J. D., Bove, K. E., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00093-3 · Cited by 685
Self-citationMeraldi, P. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.483 · Cited by 658
Plk4-Induced Centriole Biogenesis in Human Cells
Kleylein-Sohn, J., Westendorf, J., Le Clech, M., Habedanck, R., Stierhof, Y.-D., & Nigg, E. A. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.07.002 · Cited by 659
Metadata
- Authors
- Carroll, P. E., Okuda, M., Horn, H. F., Biddinger, P., Stambrook, P. J., Gleich, L. L., Li, Y.-Q., Tarapore, P., & Fukasawa, K.
- Affiliations
- University of Cincinnati (US)
- Venue
- Oncogene
- Published
- 1999-03-18
- Volume
- 18
- Issue
- 11
- Pages
- 1935-1944
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2321611063
- Cited by
- 279
- References
- 53
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 7 · 2022: 4 · 2021: 10 · 2020: 9 · 2019: 1 · 2018: 4 · 2017: 4 · 2016: 6 · 2015: 2 · 2014: 6 · 2013: 8 · 2012: 13
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- chromosomal instability, TP53 mutation, MDM2 overexpression, breast ductal carcinoma, head and neck squamous cell carcinoma, aberrant mitosis, loss of heterozygosity, p53 inactivation, tumor suppressor loss
- MeSH terms
- Animals, Breast Neoplasms, Gene Amplification, Head and Neck Neoplasms, Humans, Nuclear Proteins, Proto-Oncogene Proteins, Gene Expression, Tumor Suppressor Protein p53, Mutagenesis, 3T3 Cells, Carcinoma, Ductal, Breast, Neoplasms, Squamous Cell, Centrosome, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.